2nd ESOP-ESO Masterclass in Oncology Pharmacy
Not eligible for ESCO credits
16.11.2015 - 20.11.2015
Strasbourg, France
MASTERCLASS
Description
Chairs: A. Astier, FR - M. Daouphars, FR - F. Lemare, FR - P. Hartvig-Honoré, SE/DK - G. Wiedemann, DE - K. Meier, DE
The ESOP-ESO Advanced Masterclass will address clinical cases covering the majority of diseases and pharmaceutical cases which can occur in the clinical setting. Cases will include less common cancer entities such as haematological malignancies, paediatric cancer, cancer of geriatric patients, treatment of patients with organ dysfunctions (renal, liver, cardiac, etc.), rare cancers as well as hematopoietic stem cell transplant patients.
The teaching format aims at preparing the oncology pharmacist to complex situations where pharmaceutical expertise is required to improve the treatment (toxicities and their management, symptom management, drug interactions of anticancer agents, management of side-effects), oncological emergencies outcomes and patient counseling.
Current practice, recent advances and emerging therapies as well as case studies highlighting pertinent issues shall be introduced. Pharmaceutical situations shall also refer to the content of prior levels like problems concerning drug stability, physico-chemical compatibility and their possible effects on the patient’s therapy.
The ESOP-ESO Advanced Masterclass will address clinical cases covering the majority of diseases and pharmaceutical cases which can occur in the clinical setting. Cases will include less common cancer entities such as haematological malignancies, paediatric cancer, cancer of geriatric patients, treatment of patients with organ dysfunctions (renal, liver, cardiac, etc.), rare cancers as well as hematopoietic stem cell transplant patients.
The teaching format aims at preparing the oncology pharmacist to complex situations where pharmaceutical expertise is required to improve the treatment (toxicities and their management, symptom management, drug interactions of anticancer agents, management of side-effects), oncological emergencies outcomes and patient counseling.
Current practice, recent advances and emerging therapies as well as case studies highlighting pertinent issues shall be introduced. Pharmaceutical situations shall also refer to the content of prior levels like problems concerning drug stability, physico-chemical compatibility and their possible effects on the patient’s therapy.
| LEARNING OBJECTIVES | ||
| • | Improve expertise to actively contribute to the multidisciplinary management of cancer patients | |
| • | Update knowledge and communication competences related to treatment administration, side-effects and stability issue | |
| • | Improve skills in establishing appropriate informative plans on treatments for patients and their relatives | |
| MAIN TOPICS | ||
| • | Clinical cases covering the majority of the diseases and pharmaceutical clinical aspects | |
| • | The hematopoietic stem cell transplant patient and other complex situations | |
| • | Toxicities and symptom management | |
| • | Drug interactions of anticancer agents | |
| • | Oncological emergencies | |
| • | Patient counseling | |
| • | Clinical trials | |
| • | Research | |
| • | Collective prescription process | |
| • | Drug and therapeutic committee | |
| • | Pharmaco-economics | |
| The Advanced Masterclass in Oncology Pharmacy is an ESOP-ESO joint event |  |
General information
FURTHER INFORMATION
ESOP Membershipservice
c/o DGOP e.V., Veritaskai 6, 21079 Hamburg
Germany
Ph +49 40 790 3356 - Fax: +49 40 791 43601
membershipservice@esop.li - www.esop.eu
ESOP Membershipservice
c/o DGOP e.V., Veritaskai 6, 21079 Hamburg
Germany
Ph +49 40 790 3356 - Fax: +49 40 791 43601
membershipservice@esop.li - www.esop.eu